伯恩斯坦将三只欧洲制药股列为最佳买入标的,板块重估在即
- 提供者Investing.com-
Investing.com -- 欧洲制药板块作为必备防御性板块重新受到关注,而伯恩斯坦已明确给出了其选择。在最近的一份研报中,该...
最新 | 最高 | 最低 | |||||
|---|---|---|---|---|---|---|---|
| 260.00 | 262.00 | 256.80 | -2.00 | -0.76% | 29.12K | ||
| 80.70 | 80.85 | 79.25 | +0.15 | +0.19% | 10.89K | ||
| 103.30 | 104.20 | 102.30 | -0.70 | -0.67% | 78.87K | ||
| 26.78 | 26.86 | 25.90 | +0.68 | +2.61% | 116.38K | ||
| 76.15 | 76.90 | 75.75 | -0.45 | -0.59% | 16.74K | ||
| 251.10 | 254.80 | 245.20 | -0.20 | -0.08% | 86.67K | ||
| 59.12 | 59.32 | 58.20 | -0.30 | -0.50% | 926.97K | ||
| 61.60 | 61.70 | 60.90 | +0.25 | +0.41% | 126.68K | ||
| 16.09 | 16.50 | 15.93 | -0.28 | -1.71% | 173.7K | ||
| 68.35 | 68.55 | 67.45 | +0.15 | +0.22% | 39.86K | ||
| 127.50 | 130.80 | 124.60 | -2.00 | -1.54% | 44.73K | ||
| 9,530.0 | 9,710.0 | 9,420.0 | -140.0 | -1.45% | 244 | ||
| 50.80 | 52.55 | 50.55 | -2.20 | -4.15% | 36.86K | ||
| 63.60 | 64.10 | 63.20 | -0.70 | -1.09% | 23.54K | ||
| 209.40 | 220.20 | 208.00 | -9.20 | -4.21% | 35.87K | ||
| 22.14 | 22.26 | 21.82 | -0.14 | -0.63% | 164.34K | ||
| 158.40 | 159.10 | 156.60 | +1.60 | +1.02% | 23.22K | ||
| 603.80 | 613.80 | 600.00 | +2.00 | +0.33% | 76.8K | ||
| 8.23 | 8.28 | 8.10 | 0.00 | 0.00% | 185.3K | ||
| 49.13 | 49.87 | 48.16 | -0.14 | -0.28% | 44.82K |
Investing.com -- 欧洲制药板块作为必备防御性板块重新受到关注,而伯恩斯坦已明确给出了其选择。在最近的一份研报中,该...
智通财经APP获悉,申万宏源发布研报称,美以军事行动致使伊朗关闭霍尔木兹海峡,从霍尔木兹海峡通行量骤降表现来看,已实现船东担忧情...
Investing.com -- DEME集团的荷兰竞争对手Boskalis周四宣布,2025财年EBITDA增长3%,达到创纪录...